Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
1.540
+0.090 (6.21%)
At close: May 12, 2025, 4:00 PM
1.500
-0.040 (-2.60%)
After-hours: May 12, 2025, 7:35 PM EDT
Editas Medicine Market Cap
Editas Medicine has a market cap or net worth of $128.91 million as of May 12, 2025. Its market cap has decreased by -70.55% in one year.
Market Cap
128.91M
Enterprise Value
-60.92M
1-Year Change
-70.55%
Ranking
Category
Stock Price
$1.54
Market Cap Chart
Since February 3, 2016, Editas Medicine's market cap has decreased from $649.70M to $128.91M, a decrease of -80.16%. That is a compound annual growth rate of -16.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 120.30M | 14.79% |
| Dec 31, 2024 | 104.80M | -87.33% |
| Dec 29, 2023 | 827.40M | 35.66% |
| Dec 30, 2022 | 609.90M | -66.42% |
| Dec 31, 2021 | 1.82B | -58.45% |
| Dec 31, 2020 | 4.37B | 187.69% |
| Dec 31, 2019 | 1.52B | 39.66% |
| Dec 31, 2018 | 1.09B | -15.40% |
| Dec 29, 2017 | 1.29B | 122.48% |
| Dec 30, 2016 | 577.90M | -11.05% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |